1van Os, J, Kapur, S. Schizophrenia. Lancet 2009; 374(9690): 635–45.
2McGuffin, P, Gottesman, II, Swerdlow, R, Binder, D, Parker, W. Risk factors for schizophrenia. N Engl J Med 1999; 341(5): 370–1.
3Van Os, J, Rutten, BP, Poulton, R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008; 34(6): 1066–82.
4Ripke, S, Neale, BM, Corvin, A, Walters, JT, Farh, K-H, Holmans, PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511(7510): 421.
5Visscher, PM, Brown, MA, McCarthy, MI, Yang, J. Five years of GWAS discovery. Am J Hum Genet 2012; 90(1): 7–24.
6Wilkinson, B, Evgrafov, OV, Zheng, D, Hartel, N, Knowles, JA, Graham, NA, et al. Endogenous cell type-specific disrupted in schizophrenia 1 interactomes reveal protein networks associated with neurodevelopmental disorders. Biol Psychiatry 2018, in press.
7Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160(4): 636–45.
8Wang, Q, Xiang, B, Deng, W, Wu, J, Li, M, Ma, X, et al. Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naive patients with schizophrenia. PLoS One 2013; 8(9): e75083.
9Dong, D, Wang, Y, Chang, X, Jiang, Y, Klugah-Brown, B, Luo, C, et al. Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: a comparative voxel-based meta-analysis. Schizophr Res 2017; 185: 41–50.
10Wang, Q, Cheung, C, Deng, W, Li, M, Huang, C, Ma, X, et al. Fronto-parietal white matter microstructural deficits are linked to performance IQ in a first-episode schizophrenia Han Chinese sample. Psychol Med 2013; 43(10): 2047–56.
11Kunimatsu, N, Aoki, S, Kunimatsu, A, Abe, O, Yamada, H, Masutani, Y, et al. Tract-specific analysis of white matter integrity disruption in schizophrenia. Psychiatry Res 2012; 201(2): 136–43.
12Skudlarski, P, Schretlen, DJ, Thaker, GK, Stevens, MC, Keshavan, MS, Sweeney, JA, et al. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry 2013; 170(8): 886–98.
13Schijven, D, Kofink, D, Tragante, V, Verkerke, M, Pulit, SL, Kahn, RS, et al. Comprehensive pathway analyses of schizophrenia risk loci point to dysfunctional postsynaptic signaling. Schizophr Res 2018; 199: 195–202.
14Ripke, S, Sanders, AR, Kendler, KS, Levinson, DF, Sklar, P, Holmans, PA, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43(10): 969.
15Langfelder, P, Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9(1): 559.
16First, MB, Spitzer, RL, Gibbon, M, Williams, JB. User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version. American Psychiatric Association, 1997.
17Kay, SR, Flszbein, A, Opfer, LA. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13(2): 261.
18Buckner, RL, Head, D, Parker, J, Fotenos, AF, Marcus, D, Morris, JC, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004; 23(2): 724–38.
19Xiang, B, Wu, J-y, Wang, Q, Li, M-L, Jiang, L-J, Deng, W, et al. Cortical surface area correlates with STON2 gene Ser307Pro polymorphism in first-episode treatment-naive patients with schizophrenia. PLoS One 2013; 8(6): e64090.
20Price, AL, Patterson, NJ, Plenge, RM, Weinblatt, ME, Shadick, NA, Reich, D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38(8): 904–9.
21Li, H, Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 2009; 25(14): 1754–60.
22McKenna, A, Hanna, M, Banks, E, Sivachenko, A, Cibulskis, K, Kernytsky, A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20(9): 1297–303.
23Liu, JZ, Mcrae, AF, Nyholt, DR, Medland, SE, Wray, NR, Brown, KM, et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87(1): 139–45.
24Menche, J, Sharma, A, Kitsak, M, Ghiassian, SD, Vidal, M, Loscalzo, J, et al. Uncovering disease-disease relationships through the incomplete interactome. Science 2015; 347(6224): 1257601.
25Wang, L, Matsushita, T, Madireddy, L, Mousavi, P, Baranzini, S. PINBPA: Cytoscape app for network analysis of GWAS data. Bioinformatics 2015; 31(2): 262–4.
26Wang, J, Duncan, D, Shi, Z, Zhang, B. WEB-based gene set analysis toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013; 41(W1): W77–83.
27Dougherty, JD, Schmidt, EF, Nakajima, M, Heintz, N. Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Res 2010; 38(13): 4218–30.
28Wu, MC, Kraft, P, Epstein, MP, Taylor, DM, Chanock, SJ, Hunter, DJ, et al. Powerful SNP-set analysis for case-control genome-wide association studies. Am J Hum Genet 2010; 86(6): 929–42.
29Kunimatsu, N, Aoki, S, Kunimatsu, A, Abe, O, Yamada, H, Masutani, Y, et al. Tract-specific analysis of white matter integrity disruption in schizophrenia. Psychiatry Res 2012; 201(2): 136–43.
30Lei, W, Li, N, Deng, W, Li, M, Huang, C, Ma, X, et al. White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study. Sci Rep 2015; 5: 12994.
31Gupta, CN, Chen, J, Liu, J, Damaraju, E, Wright, C, Perrone-Bizzozero, NI, et al. Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. Front Hum Neurosci 2015; 9: 100.
32Han, S, Yang, B-Z, Kranzler, HR, Liu, X, Zhao, H, Farrer, LA, et al. Integrating GWASs and human protein interaction networks identifies a gene subnetwork underlying alcohol dependence. Am J Hum Genet 2013; 93(6): 1027–34.
33Andrews, JL, Fernandez-Enright, F. Investigation of genetic variants in ubiquitin enzyme genes involved in the modulation of neurodevelopmental processes: a role in schizophrenia susceptibility? Genet Res (Camb) 2014; 96: e15.
34Li, X, Zhang, W, Lencz, T, Darvasi, A, Alkelai, A, Lerer, B, et al. Common variants of IRF3 conferring risk of schizophrenia. J Psychiatr Res 2015; 64: 67–73.
35Shiina, T, Hosomichi, K, Inoko, H, Kulski, JK. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 2009; 54(1): 15–39.
36McAllister, AK. Major histocompatibility complex I in brain development and schizophrenia. Biol Psychiatry 2014; 75(4): 262–8.
37Collins, SE, Noyce, RS, Mossman, KL. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004; 78(4): 1706–17.
38Melnik, A, Tauber, S, Dumrese, C, Ullrich, O, Wolf, SA. Murine adult neural progenitor cells alter their proliferative behavior and gene expression after the activation of Toll-like-receptor 3. Eur J Microbiol Immunol 2012; 2(3): 239–48.
39Li, X, Zhang, W, Lencz, T, Darvasi, A, Alkelai, A, Lerer, B, et al. Common variants of IRF3 conferring risk of schizophrenia. J Psychiatr Res 2015; 64: 67–73.
40Levenga, J, Wong, H, Milstead, RA, Keller, BN, LaPlante, LE, Hoeffer, CA. AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. eLife 2017; 6: e30640.
41Liu, S, Ma, Y, Lee, E. NMDA receptor signaling mediates the expression of protein inhibitor of activated STAT1 (PIAS1) in rat hippocampus. Neuropharmacology 2013; 65: 101–13.
42Bulayeva, K, Lesch, K-P, Bulayev, O, Walsh, C, Glatt, S, Gurgenova, F, et al. Genomic structural variants are linked with intellectual disability. J Neural Transm 2015; 122(9): 1289–301.
43Alsayegh, KN, Sheridan, SD. Knockdown of CDK2AP1 in human embryonic stem cells reduces the threshold of differentiation. PLoS One 2018; 13(5): e0196817.
44Manolio, TA, Collins, FS, Cox, NJ, Goldstein, DB, Hindorff, LA, Hunter, DJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461(7265): 747–53.
45Genovese, G, Fromer, M, Stahl, EA, Ruderfer, DM, Chambert, K, Landén, M, et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat Neurosci 2016; 19(11): 1433.
46Brown, AS. The environment and susceptibility to schizophrenia. Prog Neurobiol 2011; 93(1): 23–58.
47Bauman, MD, Iosif, A-M, Smith, SE, Bregere, C, Amaral, DG, Patterson, PH. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry 2014; 75(4): 332–41.
48Li, Q, Leung, Y, Zhou, I, Ho, L, Kong, W, Basil, P, et al. Dietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model. Transl Psychiatry 2015; 5(9): e641.
49Li, Q, Cheung, C, Wei, R, Cheung, V, Hui, ES, You, Y, et al. Voxel-based analysis of postnatal white matter microstructure in mice exposed to immune challenge in early or late pregnancy. Neuroimage 2010; 52(1): 1–8.
50Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci 2015; 18(2): 199–209.
51Jarome, TJ, Lubin, FD. Histone lysine methylation: critical regulator of memory and behavior. Rev Neurosci 2013; 24(4): 375–87.
52Ibi, D, González-Maeso, J. Epigenetic signaling in schizophrenia. Cell Signal 2015; 27(10): 2131–6.